ILLUMINA INC (ILMN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ILMN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ILMN | Former CEO & Executive Chair of Laboratory Corporation of America; Chair, President & CEO | 69 | ["Board Chair at Privia Health","Director at Smith & Nephew","Managing Member, KingMan LLC","Extensive experience in healthcare and life sciences sectors","Operational excellence and commercial initiatives","Leading transformational change in businesses through M&A and organic initiatives","Building high-performing management teams","Former CEO & Executive Chair of Laboratory Corporation of America"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LH | Chairman, President & CEO, Laboratory Corporation of America Holdings; Chairman and Chief Executive Officer | 62 | ["Nearly twenty years’ experience with the Company","Corporate operations","Strategic planning","Corporate administration","Deep understanding of the clinical laboratory industry","Business strategy","Finance","Sales and marketing","Mergers and acquisitions","Risk management","Executive management"] | ["Seattle Science Foundation","American Clinical Laboratory Association","Emily Krzyzewski Center","Path, Inc."] | 2019 |
| CAH | Chairman, President and CEO, Laboratory Corporation of America Holdings | 60 | [] | ["Chair"] | 2016 |
Biography sourced from the proxy statement filing.
Profile New Director Nominee Age: 69 Education B.A. in Public and International Affairs from Princeton University J.D. from University of Pennsylvania Law School Relevant Expertise Mr. King has extensive experience in the healthcare and life sciences sectors in executive and non-executive roles. His experience includes operating a complex business at scale, leading operational excellence and commercial initiatives, building a high-performing culture, leading transformational change in businesses through M&A and organic initiatives, and building high-performing management teams. Career Highlights Chair, President & CEO, Laboratory Corporation of America Holdings (LabCorp) (2007 2019) and Executive Chair (2019 2020) Managing Member, KingMan LLC, provider of strategic consulting services for stakeholders across the healthcare system (since 2021) Operating Partner, Pritzker Private Capital (2020 2021) Former CEO, Current Director & Chairman, Fortis Life Sciences (2023 Present) Prior to joining LabCorp, Mr. King was a partner at Hogan & Hartson LLP (now Hogan Lovells) and an Assistant U.S. Attorney for the District of Maryland Public Board Service Privia Health Group Inc. (Chair since 2021) Smith & Nephew PLC (since 2025) ZimVie Inc. (Chair 2022 2025) LabCorp (Board 2007 2020; Executive Chair 2009 2019; Non-Executive Chair 2019 2020) Non-Public Board Service PathGroup (Chair 2022) LGC Limited (Chair since 2023) AMSURG Corp. (Chair since 2023) Novant Health (Since 2021) AMR Clinical (Chair 2021 2026) HealthChannels, LLC (Executive Chair 2021 2026) VaxCare, LLC (2021 2025) Of Note Forbes America s Most Innovative Leaders (2019) Former Member of the Advisory Board for Duke University s Robert J. Margolis, MD, Center for Health Policy